Company Directory / Alternative Medicine
PrivateFor profitAlternative MedicineDallas, United States
Onconano Medicine
OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.
- Founded
- 2014 12 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $188M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
12 years old.
Reach
Website ranked #15,828,629 in the world for traffic, about 1 visits a month.
What it does
Alternative MedicineBiotechnologyHealth CareNanotechnology
Funding, as listed
$188M currency not stated
- Rounds7
- LatestSeries b, Oct 2021
- Investors4, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Onconano Medicine, field by field. Contact details are held but never shown.
The company
- Name
- Onconano Medicine
- Type
- For profit
- Status
- Private
- Founded
- 2014
- Founders
- Ravi Srinivasan
- Industry
- Alternative Medicine
- Categories
- Alternative Medicine, Biotechnology, Health Care, Nanotechnology
Where
- City
- Dallas
- Country
- United States
- Markets
- Dallas/Fort Worth Metroplex, Southern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #15,828,629
- Monthly web visits
- 1
Funding, as listed
- Total
- 188,135,995 (currency not stated)
- Rounds
- 7
- Latest round
- Series b
- Latest round date
- Oct 2021
- Investors
- 4
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Onconano Medicine may be growing as it has recently appointed a new Chief Executive Officer and promoted an internal candidate to Chief Operating Officer, which could indicate a strategic strengthening of its leadership team. Additionally, the company has initiated a Phase 1 study and successfully dosed the first patient with ONM-501 for advanced solid tumors and lymphomas, suggesting progress in its clinical development pipeline. These developments, particularly the advancement of clinical trials, are often associated with an increase in operational activities and potential growth in the biotech sector.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Alternative Medicine in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.